 |
 |
 |
 |
 |
|
|
| Article 1 to 6 out of 6 concerning MDS Inc.
|
-
MDS Pharma Services Strengthens Therapeutic Focus on Respiratory and Metabolic Disorders
(23 May 2008)
Dr. Bernard Tisserand and Dr. Jonny Salyer appointed Executive Medical Directors to provide leadership and expertise for late stage clinical studies
MDS Pharma Services has named two experienced medical professionals to lead its late stage clinical trial management activities related to respiratory ailments and metabolic disorders. Dr. Bernard Tisserand and Dr. Jonny L. Salyer have been named ...
-
MDS Pharma Services Expands Presence in Latin America with Sao Paulo Office
(30 Jan 2008)
MDS Pharma Services has established an office in Sao Paulo, Brazil, to provide expanded capabilities in global clinical trial management. The new office joins nearly two dozen other MDS Pharma Services late stage clinical trial management offices in ...
-
MDS Pharma Services opens its first U.S. central lab
(19 Oct 2006)
MDS Pharma Services announced that it has established its first central lab in the United States. The new 15,000 square-foot facility, located in North Brunswick, New Jersey is now fully operational, expanding MDS Pharma Services capabilities in ...
-
MDS to Sell Diagnostics Business to Borealis Infrastructure Management in $1.3B Transaction
(09 Oct 2006)
Important Milestone in Executing Global Life Sciences Strategy
MDS Inc. announced it signed an agreement to sell its Canadian laboratory services business, MDS Diagnostic Services, to Borealis Infrastructure Management Inc. in a CAD $1.325 billion transaction. This strategic sale is designed to shift the ...
-
Researchers Identify New Protein Biomarker Candidates That May Lead To Better Diagnosis And Treatment For Age-Related Diseases
(25 Aug 2006)
Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies Targeted in Protein Study Enabled by Applied Biosystems/MDS SCIEX's Advanced Technologies
Applied Biosystems, an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc., announced the outcome of the scientific research community's most extensive, spinal fluid-based protein study on neurodegenerative ...
-
MDS Sciex Opens Manufacturing Facility in Singapore
(03 Mar 2006)
MDS Sciex, the analytical instrumentation and technology solutions division of MDS Inc., announced the official opening of its new manufacturing facility in Singapore. The new Singapore manufacturing facility is MDS Sciex's first site in the Asia ...
 |
|
|
|
|